Genetic and epigenetic alterations in pancreatic carcinogenesis - Wikidata - awgldk - TriplyDB

Genetic and epigenetic alterations in pancreatic carcinogenesis

Genetic and epigenetic alterations in pancreatic carcinogenesis

http://www.wikidata.org/entity/Q24598655

about

Met receptor tyrosine kinase signaling induces secretion of the angiogenic chemokine interleukin-8/CXCL8 in pancreatic cancer KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression.Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas.TGF-β mediated DNA methylation in prostate cancer.Systems biology of cancer: a challenging expedition for clinical and quantitative biologists MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer Nuclear receptors and pathogenesis of pancreatic cancer.The rescue of miR-148a expression in pancreatic cancer: an inappropriate therapeutic tool Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine.Ploidy and DNA index as prognostic factors in resected pancreatic ductal adenocarcinoma - a review of the literature.The loss of miR-26a-mediated post-transcriptional regulation of cyclin E2 in pancreatic cancer cell proliferation and decreased patient survival.Pharmacological activation of myosin II paralogs to correct cell mechanics defects.Pancreatic cancer patient survival correlates with DNA methylation of pancreas development genes.Selective impact of CDK4/6 suppression on patient-derived models of pancreatic cancer.DPC4 expression in the small intestinal adenocarcinomas.RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients.Report on a patient with a 12q24.31 microdeletion inherited from an insulin-dependent diabetes mellitus father.Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma.Mutant KRAS is a druggable target for pancreatic cancer.Orphan nuclear receptor Nurr1 as a potential novel marker for progression in human pancreatic ductal adenocarcinoma.Papanicolaou Society of Cytopathology new guidelines have a greater ability of risk stratification for pancreatic endoscopic ultrasound-guided fine-needle aspiration specimens.Molecular Subtyping of Pancreatic Cancer: Translating Genomics and Transcriptomics into the Clinic.Targeting the Ras-ERK pathway in pancreatic adenocarcinoma.Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9.Pancreatic Cancer: Clinical Significance of Biomarkers COUP-TFII in pancreatic adenocarcinoma: clinical implication for patient survival and tumor progression.Targeting miR-21 for the therapy of pancreatic cancer Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes.MiR-377 reverses cancerous phenotypes of pancreatic cells via suppressing DNMT1 and demethylating tumor suppressor genes.Environmental factors and risk of aggressive prostate cancer among a population of New Zealand men - a genotypic approach.Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma.Voltammetric behaviour of free DNA bases, methylcytosine and oligonucleotides at disposable screen printed graphite electrode platforms.Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma.DNA methyltransferase 3a modulates chemosensitivity to gemcitabine and oxaliplatin via CHK1 and AKT in p53‑deficient pancreatic cancer cells.Promoter hypermethylation in plasma-derived cell-free DNA as a prognostic marker for pancreatic adenocarcinoma staging.Panobinostat as Pan-deacetylase Inhibitor for the Treatment of Pancreatic Cancer: Recent Progress and Future Prospects.Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling.Antitumor activity of sorafenib plus CDK4/6 inhibitor in pancreatic patient derived cell with KRAS mutation Histo-molecular oncogenesis of pancreatic cancer: From precancerous lesions to invasive ductal adenocarcinoma

P2860

Q27334957-7BA91819-B530-473A-B9AB-C15F1BDA1BFB Q27853365-62FD7461-92D8-485C-95FF-6E593C409A6D Q33643873-0D7E9FBF-45EC-4D96-966C-0661D7B47BB0 Q34008627-1299F59D-07CF-4F74-8D1E-F7FB5FCCD31D Q34039935-BFE1C6C4-E218-4426-9921-8513205CF0FF Q34064296-E80AFAB0-7FCF-4BDE-9BFB-CF4CBC3E158E Q34093798-2B244063-BDDC-447D-BCD4-5F40058BFBA6 Q34168476-C34E72A9-3618-4007-A055-6F0ACDD5A9DD Q34576658-3966B810-2CAC-4F7E-B8BB-A7050D4A2B47 Q34657038-4155D068-B9F8-42C3-BC20-F8137865B414 Q34990040-29ECC4FA-5FDB-4AD8-8F44-047CF7EEA36D Q35014682-6813491C-7783-433F-8A76-564D77BE4731 Q35062582-8806CCCE-6C82-4CBE-9FC8-0A36C98C2AF7 Q35651346-912BDA6D-4FF3-442E-89A1-C61330CF08DE Q36140625-75D8E814-9DAE-458C-A0B0-EF9B25BD4FE5 Q36374593-D35814F7-2BC7-42E8-9086-2A62D8C4495C Q36414524-D1A2E4D1-DAA4-481E-B23C-148C76ABE39E Q36802809-4E5FFE5B-AA6B-4F43-A8C8-D8CCBA46F9B8 Q37333036-780BE5A5-7208-4FEF-90DF-307CFBC6F9D4 Q37409321-B26F806F-5936-4C6C-8E03-853FE5A57D9D Q37697716-11401C94-B0A2-42A4-AF09-70EF4075C217 Q37702678-637ED615-E3C2-4C90-A848-CDC813417EA6 Q37726365-0818E4F5-C9D3-42C6-84E7-A54E9C801F8A Q38053855-FDE2FED0-22E8-4893-AA3B-22986A04D9D9 Q38129331-0ACFCD99-DACB-4CC3-99BC-97D97D76FE44 Q38671234-0D480FED-43FA-4343-B1AA-D4BFEDDABD86 Q39079666-26AF9A93-1797-4318-8868-C74BF17BEC2F Q39182251-227F8B6C-C0A0-49C7-A233-DB7BFF16C274 Q39359422-5C78BAF6-11C0-4F2C-8911-C3438C7AA60D Q40101683-BB9264BE-D259-4C43-A4FC-5C7B632D44CB Q40311743-10F53078-5E89-4C56-A205-77A120FC916D Q41766645-C9812330-F1BC-4A2D-922D-EE2C0D6C1AD4 Q44550654-8D976F32-3353-4B19-9D24-0F3AA34FEBE5 Q47162128-D0832F15-2A81-4169-8B0A-D4E1B95909B7 Q47634492-646B4ECC-BC3D-4738-83EB-614DE871B1E3 Q48149907-4969E773-F0B1-4D1E-BAF8-64C30D282A56 Q51034578-FCF712C9-C03D-412C-AC56-EFEB70BE3B94 Q53242589-C75D6D46-B91F-4260-BC46-013A536CF31E Q57116328-DF0E8518-10FD-4CD3-BB7B-69784E4802A6 Q58566683-1EA1697A-42F7-4194-84D9-68E9F03A893B

P2860

Genetic and epigenetic alterations in pancreatic carcinogenesis

http://www.wikidata.org/entity/Q24598655

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Genetic and epigenetic alterations in pancreatic carcinogenesis

@ast

Genetic and epigenetic alterations in pancreatic carcinogenesis

@en

Genetic and epigenetic alterations in pancreatic carcinogenesis

@nl

type

label

Genetic and epigenetic alterations in pancreatic carcinogenesis

@ast

Genetic and epigenetic alterations in pancreatic carcinogenesis

@en

Genetic and epigenetic alterations in pancreatic carcinogenesis

@nl

prefLabel

Genetic and epigenetic alterations in pancreatic carcinogenesis

@ast

Genetic and epigenetic alterations in pancreatic carcinogenesis

@en

Genetic and epigenetic alterations in pancreatic carcinogenesis

@nl

P1433

Q24598655-3F074049-C0F3-45C5-A9FF-A67FD7DB468B

P1476

Q24598655-6B1FD8A2-9734-404A-B89E-88BE7538E6FC

P2093

Q24598655-01C3135D-3FC6-44EF-9CA1-6FC931FD3209

Q24598655-1BB54F44-40DB-4A05-89B4-C58262FB080D

Q24598655-36D8011E-AE53-4EFC-892C-223B5508A221

Q24598655-4DD58960-6772-4F6A-993F-02637EF4F646

Q24598655-5DC821CE-11AA-44F6-BBF7-43F3854C00E0

Q24598655-8CA03FB0-1A06-484A-AAA5-973114B9BCDB

Q24598655-8FDBA7C5-9E61-453A-9216-C6879D1BC638

Q24598655-A04A6A73-B259-45CD-A939-686E19C5C3E3

P2860

Q24598655-047DB327-B73A-434C-B813-9682FD869A6B

Q24598655-06F9A930-5EF6-4952-8773-95AF6673327B

Q24598655-0912001F-1A9F-4600-AD4A-9D21F07CB538

Q24598655-0A48A13F-FBB1-4C82-AB6F-E633E84AC54A

Q24598655-0C5F6046-A647-4F4D-974B-9271B22121E2

Q24598655-0FE924A3-9343-4F96-8113-BC949C663AE0

Q24598655-1218A6B5-B2D3-434C-ADF5-F48491E059E8

Q24598655-13D2BED8-10AA-428F-B6B0-D9A0AB8C2B09

Q24598655-14EF5F9A-5BAE-43FF-92CB-E72519E019E8

Q24598655-1744C529-B22B-42F8-AB05-B419A9096ADD

P304

Q24598655-52B8E106-4614-4D6D-8C4D-D117D24825FE

P31

Q24598655-2A13B2F5-8B78-4EBD-8021-D9541AC97D0A

P3181

Q24598655-2DE4D14B-1B37-49B9-8A04-9E2EE1586C31

P356

Q24598655-DDB4FB6F-D785-4CB6-B1E6-00DE729F0B6E

P407

Q24598655-B408C8D5-79F5-4358-9BE3-9680C26C66AA

P433

Q24598655-C28A0BF1-4E2E-4620-9912-B30D8C40A853

P478

Q24598655-28F4ED36-55A6-4712-9066-4AF47ECDB95B

P577

Q24598655-A81EFDF1-9514-42E6-BE17-C72EC00DD89C

P5875

Q24598655-A36B5EC5-837F-442E-90FB-176E206DC1A6

P698

Q24598655-C2E6ECBA-90EB-4939-B45C-2BDC23F127AC

P932

Q24598655-365D8121-8D88-4972-98D4-EFFC27971D62

P3181

P356

138920211794520132

P1433

Current Genomics

P1476

Genetic and epigenetic alterations in pancreatic carcinogenesis

@en

P2093

Flavie Sicard

http://www.w3.org/2001/XMLSchema#string

Hubert Lulka

http://www.w3.org/2001/XMLSchema#string

Janick Selves

http://www.w3.org/2001/XMLSchema#string

Jérôme Torrisani

http://www.w3.org/2001/XMLSchema#string

Louis Buscail

http://www.w3.org/2001/XMLSchema#string

Naïma Hanoun

http://www.w3.org/2001/XMLSchema#string

Pierre Cordelier

http://www.w3.org/2001/XMLSchema#string

Yannick Delpu

http://www.w3.org/2001/XMLSchema#string

P2860

The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors

Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas

A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes

Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas

BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets

MicroRNAs: genomics, biogenesis, mechanism, and function

Identification of pancreatic cancer stem cells

Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer

P304

15-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4781814

http://www.w3.org/2001/XMLSchema#string

P356

10.2174/138920211794520132

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51614112

http://www.w3.org/2001/XMLSchema#string

P698

21886451

http://www.w3.org/2001/XMLSchema#string

P932

3129039

http://www.w3.org/2001/XMLSchema#string